Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Protara Therapeutics
TARA
$230M
| $2.38M | ﹤0.01% |
5,125
+382
| +8% | +$168K |
|
|
HERO
3327
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $2.38M | ﹤0.01% |
5,680,877
-1,534,649
| -21% | -$1.08M |
|
|
COSI
3328
DELISTED
COSI INC NEW COM STK (DE)
COSI
| $2.38M | ﹤0.01% |
894,149
+37,900
| +4% | +$94.8K |
|
|
ANCX
3329
DELISTED
Access National Corp
ANCX
| $2.38M | ﹤0.01% |
126,839
+1,600
| +1% | +$28.9K |
|
|
FSAM
3330
DELISTED
Fifth Street Asset Management Inc. Class A
FSAM
| $2.36M | ﹤0.01% |
209,319
+193,517
| +1,225% | +$2.47M |
|
|
HTCH
3331
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
| $2.35M | ﹤0.01% |
881,608
+90,655
| +11% | +$305K |
|
|
CYNI
3332
DELISTED
CYAN INC COM
CYNI
| $2.35M | ﹤0.01% |
588,389
+18,283
| +3% | +$64.4K |
|
|
BIND
3333
DELISTED
BIND THERAPEUTICS INC
BIND
| $2.35M | ﹤0.01% |
427,702
+244,424
| +133% | +$1.5M |
|
3334
Identive
INVE
$61.2M
| $2.34M | ﹤0.01% |
272,853
+75,887
| +39% | +$880K |
|
|
WRES
3335
DELISTED
WARREN RESOURCES INC
WRES
| $2.34M | ﹤0.01% |
2,628,754
+265,180
| +11% | +$312K |
|
|
TVRD
3336
Tvardi Therapeutics
TVRD
$23.1M
| $2.33M | ﹤0.01% |
6,438
+1,574
| +32% | +$596K |
|
|
HMTV
3337
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $2.33M | ﹤0.01% |
183,922
+4,448
| +2% | +$56.6K |
|
|
AKAO
3338
DELISTED
Achaogen Inc
AKAO
| $2.32M | ﹤0.01% |
238,020
+3,109
| +1% | +$35K |
|
3339
Energous
WATT
$98.5M
| $2.3M | ﹤0.01% |
407
+78
| +24% | +$462K |
|
|
MSL
3340
DELISTED
Midsouth Bancorp, Inc.
MSL
| $2.3M | ﹤0.01% |
156,162
-1,153
| -0.7% | -$17.3K |
|
3341
Timberland Bancorp
TSBK
$355M
| $2.3M | ﹤0.01% |
212,126
| – | – |
|
|
PHII
3342
DELISTED
PHI, Inc.
PHII
| $2.3M | ﹤0.01% |
77,241
+75
| +0.1% | +$2.53K |
|
|
FRS
3343
DELISTED
FRISCH'S RESTAURANTS INC
FRS
| $2.29M | ﹤0.01% |
84,488
+1,400
| +2% | +$38.5K |
|
|
DXM
3344
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
| $2.29M | ﹤0.01% |
547,405
+55,434
| +11% | +$373K |
|
3345
Crawford & Co Class A
CRD.A
$625M
| $2.29M | ﹤0.01% |
302,834
+86
| +0% | +$669 |
|
3346
Triumph Financial Inc
TFIN
$1.81B
| $2.28M | ﹤0.01% |
167,002
+2,379
| +1% | +$31K |
|
|
MBRG
3347
DELISTED
Middleburg Financial Corp
MBRG
| $2.28M | ﹤0.01% |
123,791
+1,175
| +1% | +$21.5K |
|
|
ENFC
3348
DELISTED
Entegra Financial Corp.
ENFC
| $2.28M | ﹤0.01% |
146,841
+26,032
| +22% | +$397K |
|
3349
Lisata Therapeutics
LSTA
$9.74M
| $2.27M | ﹤0.01% |
5,968
+412
| +7% | +$223K |
|
3350
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $2.26M | ﹤0.01% |
18,471
+8,043
| +77% | +$953K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.